Literature DB >> 12937971

Concepts of immunostimulation to increase antiparasitic drug action.

K Noel Masihi1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12937971     DOI: 10.1007/s00436-002-0774-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


× No keyword cloud information.
  57 in total

1.  IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.

Authors:  I A Khan; L Casciotti
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection.

Authors:  M B Nickdel; F Roberts; F Brombacher; J Alexander; C W Roberts
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 3.  Fighting infection using immunomodulatory agents.

Authors:  K N Masihi
Journal:  Expert Opin Biol Ther       Date:  2001-07       Impact factor: 4.388

Review 4.  Immunomodulators in infectious diseases: panoply of possibilites.

Authors:  K N Masihi
Journal:  Int J Immunopharmacol       Date:  2000-12

5.  Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.

Authors:  P G Fallon; E J Richardson; G J McKenzie; A N McKenzie
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.

Authors:  J Lehmann; K H Enssle; I Lehmann; A Emmendörfer; M L Lohmann-Matthes
Journal:  J Interferon Cytokine Res       Date:  2000-01       Impact factor: 2.607

7.  Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.

Authors:  S Matsumoto; H Yukitake; H Kanbara; H Yamada; A Kitamura; T Yamada
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

8.  A distinct role for interleukin-13 in Th2-cell-mediated immune responses.

Authors:  G J McKenzie; A Bancroft; R K Grencis; A N McKenzie
Journal:  Curr Biol       Date:  1998-03-12       Impact factor: 10.834

9.  Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection.

Authors:  D Rivier; P Bovay; R Shah; S Didisheim; J Mauël
Journal:  Parasite Immunol       Date:  1999-09       Impact factor: 2.280

10.  Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection.

Authors:  S K Bliss; B A Butcher; E Y Denkers
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

View more
  1 in total

1.  Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.

Authors:  Eduardo Seiji Yamamoto; Bruno Luiz S Campos; Márcia Dalastra Laurenti; João H G Lago; Simone dos Santos Grecco; Carlos E P Corbett; Luiz Felipe D Passero
Journal:  Parasitol Res       Date:  2013-10-31       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.